PerkinElmer SCID-SMA Kit Gets FDA Authorization
PerkinElmer has announced that the FDA has authorized the marketing of the EONIS SCID-SMA assay kit for the diagnosis of SMA and SCID.
Read MorePosted by Chris Wolski | Nov 14, 2022 | Immunoassay Reagents & test Kits |
PerkinElmer has announced that the FDA has authorized the marketing of the EONIS SCID-SMA assay kit for the diagnosis of SMA and SCID.
Read MorePosted by Andy Lundin | Nov 10, 2022 | Covid 19 |
COVID “Test to Treat” sites, which provide testing, diagnosis, and access to COVID treatment, may not be accessible to those who need it.
Read MorePosted by Chris Wolski | Nov 9, 2022 | Gastrointestinal Infections |
ProciseDx Inc. announces it has received FDA clearance for its ProciseDx instrument and C reactive Protein (CRP) test.
Read MorePosted by Andy Lundin | Nov 8, 2022 | Tuberculosis |
Pioneering artificial intelligence (AI) which automatically diagnoses lung diseases could ease winter pressures on hospitals.
Read MorePosted by Andy Lundin | Nov 7, 2022 | Covid 19, Flu & Respiratory Infections |
Researchers have discovered a high prevalence of COVID co-infections in central Missouri during the 2021-2022 flu season.
Read More